Article ; Online: Phospho-Tau 181 quantification method for Alzheimer's disease based on an array 2D biosensor combined with surface plasmon resonance imaging.
2024 Volume 271, Page(s) 125736
Abstract: Alzheimer's disease is among the neurodegenerative diseases for which there is a lack of rapid, effective, and non-invasive diagnostic methods. The development of a phospho-Tau 181 assay biosensor is therefore a response to the need for methods to ... ...
Abstract | Alzheimer's disease is among the neurodegenerative diseases for which there is a lack of rapid, effective, and non-invasive diagnostic methods. The development of a phospho-Tau 181 assay biosensor is therefore a response to the need for methods to diagnose AD. The present work was aimed at developing a fast, selective, and repeatable method for the quantitative determination of phospho-Tau 181, which could be used even during routine blood tests. Our method is a form of what is called liquid biopsy. The developed method underwent validation, as a result of which its analytical parameters were determined. An LOQ of 3.35 pg mL |
---|---|
MeSH term(s) | Humans ; Alzheimer Disease/diagnostic imaging ; tau Proteins ; Surface Plasmon Resonance/methods ; Biomarkers ; Biosensing Techniques ; Amyloid beta-Peptides |
Chemical Substances | tau Proteins ; Biomarkers ; Amyloid beta-Peptides |
Language | English |
Publishing date | 2024-02-02 |
Publishing country | Netherlands |
Document type | Journal Article |
ZDB-ID | 1500969-5 |
ISSN | 1873-3573 ; 0039-9140 |
ISSN (online) | 1873-3573 |
ISSN | 0039-9140 |
DOI | 10.1016/j.talanta.2024.125736 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.